A Comprehensive Guide to Cambrex's New Liquid-Phase Peptide Synthesis Manufacturing Technology
Cambrex, a leading global contract development and manufacturing organization (CDMO), announced today that Snapdragon Chemistry, a Cambrex company, has successfully developed a new liquid-phase peptide synthesis (LPPS) technology that uses traditional active pharmaceutical ingredient (API) batch reactors and continuous flow, eliminating the need for specialized solid-phase reactors. This innovative LPPS technology significantly minimizes solvent demand and the need for additional reagents when compared to traditional solid-state peptide synthesis processes.